These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3475610)

  • 1. Oral ciprofloxacin in the treatment of 14 patients with bacterial pneumonia.
    Wollschlager CM; Raoof S; Khan FA
    N Y State J Med; 1987 Jun; 87(6):330-3. PubMed ID: 3475610
    [No Abstract]   [Full Text] [Related]  

  • 2. Follow-up therapy with ciprofloxacin in severe infection, an alternative to parenteral treatment.
    Bassaris HP; Chrysanthopoulos CJ; Skouelis AT; Starakis JC
    J Chemother; 1989 Jul; 1(4 Suppl):676-7. PubMed ID: 16312588
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral ciprofloxacin for treatment of chronic osteomyelitis.
    Yamaguti A; Trevisanello C; Lobo IM; Carvalho MC; Bortoletto ML; Silva ML; Brasil Filho R; Levi GC; Mendonça JS
    Int J Clin Pharmacol Res; 1993; 13(2):75-9. PubMed ID: 8354592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of ciprofloxacin per os in treatment of serious infections.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Beziau H
    Chemioterapia; 1987 Jun; 6(2 Suppl):391-4. PubMed ID: 3509456
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ
    Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ciprofloxacin for treatment of severe infections.
    Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
    Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peroral ciprofloxacin in the therapy of infections in oncology patients].
    Krcméry V; Horníková M; Koza I; Fuchsberger P; Spánik S; Sufliarsky J; Mardiak J; Sitáni L; Milosovic P
    Cas Lek Cesk; 1990 Oct; 129(42):1337-8. PubMed ID: 2257584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacterial etiological factors and the treatment of pneumonia in hospitalized patients].
    Bek-Lissner E; Bergson H; Graczyk J; Kucharska A
    Pneumonol Pol; 1977; 45(10-11):659-68. PubMed ID: 928145
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of ciprofloxacin: an interesting new oral antibiotic.
    Berman SJ
    Hawaii Med J; 1988 Apr; 47(4):162-4. PubMed ID: 3290154
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
    Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ
    Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic comparison of sequential IV/oral ciprofloxacin versus ceftazidime in the treatment of nosocomial pneumonia.
    Paladino JA
    Can J Hosp Pharm; 1995 Oct; 48(5):276-83. PubMed ID: 10152782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
    De Wilde R
    J Chemother; 1989 Jul; 1(4 Suppl):896-7. PubMed ID: 16312693
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
    Scully BE; Jules K; Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
    Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.